(Q48908840)

16 February 2018

title

An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. (English)

1 reference

16 February 2018

1 reference

Marta Serati

2

0 references

Bernardo Dell'Osso

object named as

Bernardo Dell'Osso

6

0 references

author name string

A Carlo Altamura

1

1 reference

16 February 2018

Alessandra Albano

3

1 reference

16 February 2018

Riccardo A Paoli

4

1 reference

16 February 2018

Ira D Glick

5

1 reference

16 February 2018

publication date

18 February 2011

1 reference

16 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

16 February 2018

volume

261

1 reference

16 February 2018

issue

7

1 reference

16 February 2018

page(s)

489-508

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s00406-011-0196-4

exact match

0 references

cites work

Phenotype of schizophrenia: a review and formulation

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The concept of psychosis: historical and phenomenological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychosis: a history of the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The concept of Schizophrenia. Kraepelin-Bleuler-Schneider.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Assessment of insight in psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The Kraepelinian dichotomy: the twin pillars crumbling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Diagnosis and course of affective psychoses: was Kraepelin right?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

From Kraepelin to Kretschmer leavened by Schneider: thextransition from categories of psychosis to dimensions of variation intrinsic to homo sapiens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Genetics of affective (mood) disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric genetics: progress amid controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Imbalanced genomic imprinting in brain development: an evolutionary basis for the aetiology of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Disruption of cortical-limbic interaction as a substrate for comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Evidence for shared susceptibility in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric and medical comorbidities of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical utility: a prerequisite for the adoption of a dimensional approach in DSM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Schizophrenia: a concise overview of incidence, prevalence, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in women and men with schizophrenia: a population-based controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A Systematic Review of Mortality in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Oral health of psychiatric in-patients in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Schizophrenia and sudden cardiac death: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The thyroid-brain interaction in thyroid disorders and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Management of schizophrenia with obesity, metabolic, and endocrinological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The metabolic syndrome and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clustering of schizophrenia with other comorbidities--what can we learn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Physical illness and schizophrenia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Risk of stillbirth and neonatal death linked with maternal mental illness: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The impact of mental illness on cardiac outcomes: a review for the cardiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The current status of tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric comorbidities and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Substance use disorders in schizophrenia--clinical implications of comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Early prodromal symptoms and diagnoses before first psychotic episode in 219 inpatients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depression in the long-term course of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Co-morbid social phobia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gene-environment interplay between cannabis and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The prediction of criminal and violent recidivism among mentally disordered offenders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depressive symptoms in schizophrenia: comprehensive differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical evaluation of negative symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Fourteen-year prospective follow-up study of positive and negative symptoms in chronic schizophrenic patients dying from suicide compared to other causes of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Suicide and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Treatment of schizophrenia and comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Cannabis and the course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical complexity and person-centered integrative diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Intramuscular preparations of antipsychotics: uses and relevance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Drawing up guidelines for the attendance of physical health of patients with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Health care utilization and costs among privately insured patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gender differences in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical and substance use comorbidity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in bipolar disorder: re-prioritizing unmet needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Obesity as a correlate of outcome in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Enhanced cancer risk among patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The effects of undertreated chronic medical illnesses in patients with severe mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbidity in mania at first hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The effect of comorbid substance use disorders on the course of bipolar disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The epidemiology of DSM-III-R bipolar I disorder in a general population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Panic comorbidity with bipolar disorder: what is the manic-panic connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Anxiety disorders and suicidal behaviour: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A review of panic and suicide in bipolar disorder: does comorbidity increase risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Risk of suicide attempt and suicide death in patients treated for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Impact of childhood abuse on the course of bipolar disorder: a replication study in U.S. veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbid anxiety in bipolar disorder alters treatment and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence and risk factors associated with suicide ideation and attempts in korean college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Suicide risk in bipolar patients: the role of co-morbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbidity of eating disorders with bipolar disorder and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The prevalence and co-morbidity of subthreshold psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Antidepressants in bipolar disorder: the case for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical variables related to antidepressant-induced mania in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Antidepressant-induced mania and cycle acceleration: a controversy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Diagnosis and treatment of obsessive-compulsive disorder and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Aripiprazole: profile on efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychotic depression and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The validity of major depression with psychotic features based on a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Importance of psychotic features to long-term course in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Severe depression: is there a best approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The 'continuum of psychosis': scientifically unproven and clinically impractical.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Phenomenology and Prognostic Significance of Delusions in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Increased Mortality Among Patients Admitted With Major Psychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Panic disorder with familial bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Effect of comorbid anxiety on treatment response in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence of obesity and weight change during treatment in patients with bipolar I disorder

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

21 January 2018

12 December 2020

Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study

1 reference

12 December 2020

Neurocognitive deterioration in elderly chronic schizophrenia patients with and without PTSD.

1 reference

12 December 2020

The increasing medical burden in bipolar disorder

1 reference

12 December 2020

Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report

1 reference

12 December 2020

Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis.

1 reference

12 December 2020

Medical comorbidity in a bipolar outpatient clinical population

1 reference

12 December 2020

Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds?

1 reference

12 December 2020

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

12 December 2020

Clinical and demographic features of psychotic and nonpsychotic depression

1 reference

12 December 2020

The prevalence of migraine in patients with bipolar and unipolar affective disorders

1 reference

12 December 2020

The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey.

1 reference

12 December 2020

Delusional and nondelusional unipolar depression: further evidence for distinct subtypes

1 reference

12 December 2020

Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder

1 reference

12 December 2020

The clinical and neuroendocrine features of psychotic depression.

1 reference

12 December 2020

Hospital-based psychiatric service utilization and morbidity in multiple sclerosis

1 reference

12 December 2020

Chronology of comorbid and principal syndromes in first-episode psychosis

1 reference

12 December 2020

Symptomatologic analysis of psychotic and non-psychotic depression

1 reference

12 December 2020

Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data.

1 reference

12 December 2020

Psychotic subtyping of major depressive disorder and posttraumatic stress disorder

1 reference

12 December 2020

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

12 December 2020

Post-Traumatic Stress Disorder in subjects with schizophrenia and bipolar disorder.

1 reference

12 December 2020

Patterns of Axis I comorbidity in relation to age in patients with Bipolar Disorder: a cross-sectional analysis.

1 reference

12 December 2020

Nosologomania: DSM & Karl Jaspers' critique of Kraepelin

1 reference

12 December 2020

Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.

1 reference

12 December 2020

Comorbidity in bipolar disorder: clinical and research opportunities

1 reference

12 December 2020

Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders

1 reference

12 December 2020

Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.

1 reference

12 December 2020

Patients with multiple sclerosis presenting to psychiatric hospitals.

1 reference

12 December 2020

Parallel fluctuations of psychiatric and neurological symptoms in a patient with multiple sclerosis and bipolar affective disorder

1 reference

12 December 2020

Medical risk in patients with bipolar disorder and schizophrenia.

1 reference

12 December 2020

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

12 December 2020

The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

12 December 2020

Clinical depression in alcoholism

1 reference

12 December 2020

Does comorbid posttraumatic stress disorder affect the severity and course of psychotic major depressive disorder?

1 reference

12 December 2020

Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey

1 reference

12 December 2020

Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients

1 reference

12 December 2020

Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder

1 reference

12 December 2020

Antipsychotic medications: metabolic and cardiovascular risk

1 reference

12 December 2020

Mortality of patients with mood disorders: follow-up over 34-38 years

1 reference

12 December 2020

Premature mortality from general medical illnesses among persons with bipolar disorder: a review

1 reference

12 December 2020

Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features

1 reference

12 December 2020

Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management

1 reference

12 December 2020

Psychiatric comorbidity in older adults with bipolar disorder

1 reference

12 December 2020

How and why genetic linkage has not solved the problem of psychosis: review and hypothesis

1 reference

12 December 2020

Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5-year prospective study.

1 reference

12 December 2020

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists

1 reference

12 December 2020

Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey.

1 reference

12 December 2020

Psychotic disorders and comorbidity: somatic illness vs. side effect.

1 reference

12 December 2020

The economic impact of bipolar disorder in an employed population from an employer perspective.

1 reference

12 December 2020

Association between bipolar affective disorder and multiple sclerosis

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Akinesia and postpsychotic depression: a difficult differential diagnosis

1 reference

12 December 2020

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches

1 reference

12 December 2020

Schizophrenia and violence: systematic review and meta-analysis

1 reference

12 December 2020

Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.

1 reference

12 December 2020

Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization.

1 reference

12 December 2020

[Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].

1 reference

12 December 2020

Is delusional depression related to bipolar disorder?

1 reference

12 December 2020

Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study

1 reference

12 December 2020

Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey

1 reference

12 December 2020

Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia

1 reference

12 December 2020

Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis.

1 reference

12 December 2020

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

1 reference

12 December 2020

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

1 reference

12 December 2020

Comorbidity of fibromyalgia and psychiatric disorders

1 reference

12 December 2020

Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies

1 reference

12 December 2020

Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms

1 reference

12 December 2020

Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial

1 reference

12 December 2020

Bipolar disorder and comorbid personality psychopathology: a review of the literature

1 reference

12 December 2020

Bipolar I, bipolar II, and nonbipolar major depression among the relatives of affectively ill probands.

1 reference

12 December 2020

10.1007/S00406-011-0196-4

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

21331479

1 reference

16 February 2018